Russia Secures Sputnik Italy Output in European Vaccine Push
This content was published on March 9, 2021 - 18:51
March 9, 2021 - 18:51
(Bloomberg) Russia is pushing ahead with plans to manufacture its Covid-19 vaccine in Europe, securing a deal to produce the Sputnik V shot in Italy and discussing production in Germany and France.
Adienne Pharma & Biotech SA signed an agreement to make the vaccine at its production site in the Milan region, founder and President Antonio Francesco Di Naro said in an interview.
The Lugano, Switzerland-based company’s deal with the Russian Direct Investment Fund is the first European production agreement for the vaccine. While Russia was first to approve a shot for the general public and promoted it as a way to help end the pandemic globally, it has been slower than some rivals to scale up output.
Drift from politics to science: Russia s COVID-19 vaccine conquers Europe
vestnikkavkaza.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vestnikkavkaza.net Daily Mail and Mail on Sunday newspapers.
Russia s Sputnik V Vaccine to Be Produced in Italy amid Approval Row with EMA - Novinite com
novinite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from novinite.com Daily Mail and Mail on Sunday newspapers.
IDT Biologika und AstraZeneca vereinbaren strategische Partnerschaft zur Impfstoffherstellung / Gemeinsame Investition in Produktionskapazitäten am Standort Dessau
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.